FDA chief at odds with Congress

11/30/2006 | Washington Post, The

Dr. Andrew von Eschenbach, acting head of the FDA, refuses to give Congress all the information it seeks about the controversial antibiotic Ketek. Von Eschenbach said disclosure of the information could hinder the FDA's ability to independently and objectively evaluate drug safety and other issues. His position puts him on a collision course with Sen. Charles Grassley, R-Iowa, who is blocking Eschenbach's confirmation to be permanent head of FDA.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN